Cornerstone Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Sell
461
-28
-6% -$28.6K 0.08% 42
2026
Q1
$450K Hold
489
0.07% 43
2025
Q4
$526K Sell
489
-10
-2% -$9.56K 0.09% 42
2025
Q3
$381K Sell
499
-10
-2% -$7.44K 0.06% 43
2025
Q2
$397K Buy
509
+161
+46% +$125K 0.07% 43
2025
Q1
$287K Sell
348
-11
-3% -$9.15K 0.05% 46
2024
Q4
$277K Hold
359
0.05% 45
2024
Q3
$318K Sell
359
-10
-3% -$8.99K 0.07% 38
2024
Q2
$334K Hold
369
0.07% 39
2024
Q1
$287K Sell
369
-15
-4% -$10.7K 0.06% 41
2023
Q4
$224K Hold
384
0.06% 49
2023
Q3
$206K Buy
+384
New +$198K 0.06% 47
2023
Q2
Sell
-384
Closed -$132K 155
2023
Q1
$132K Hold
384
0.03% 57
2022
Q4
$141K Sell
384
-13
-3% -$4.61K 0.04% 54
2022
Q3
$128K Hold
397
0.03% 57
2022
Q2
$129K Hold
397
0.03% 61
2022
Q1
$114K Hold
397
0.03% 68
2021
Q4
$110K Buy
+397
New +$101K 0.03% 67
2016
Q1
Sell
-2,478
Closed -$209K 48
2015
Q4
$209K Buy
+2,478
New +$206K 0.14% 41
2015
Q1
Sell
-4,684
Closed -$323K 45
2014
Q4
$323K Buy
+4,684
New +$316K 0.25% 37

Other funds holding LLY

Cornerstone Management's LLY Position: Q2 2026 in Review

Cornerstone Management reduced its Eli Lilly (LLY) stake by 5.7% in Q2 2026, selling an estimated $28.6K and leaving 461 shares worth $553K. The position accounts for 0.08% of the portfolio, ranked #42.

Cornerstone Management first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cornerstone Management held 461 shares of Eli Lilly worth $553K as of Q2 2026.
  • Cornerstone Management sold 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 0.08% of Cornerstone Management's portfolio in Q2 2026, its #42 holding.
  • Cornerstone Management first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cornerstone Management's 13F filing for Q2 2026, filed 16 Jul 2026.